NICE approves RNAi therapy for porphyria
This week, we look at the latest gene silencing treatment approved by NICE – this time for an acute form of porphyria
Sequencing Covid-19: 1 million genomes
As the UK reaches a mega sequencing milestone, we look at how the data could be used to better prepare us for the future
RNAi: a new approach to combat cholesterol
The new cholesterol drug inclisiran is currently making headlines after being approved for use in the NHS, but how does it work?
New data diversity initiative launches
This week, we look at a transformative programme that aims to rapidly make genomic datasets more representative
Screening the healthy for monogenic variants
As the NHS moves towards a preventative healthcare strategy, will genomic screening for healthy people become more common?
NHS targets better diabetes care with genomic testing
New initiative aims to find thousands of people with a rare, inherited form of diabetes
Newborn screening: time for a genomic approach?
This week, we explore how genomics could help expand the newborn screening programme to test for many more genetic conditions
PCR: more than just a Covid test
An old friend has been thrust into the limelight. We take a look at how PCR works and its place in Covid testing and beyond
Trial underway for hATTR therapy
The novel ‘one off’ treatment could change the lives of those living with the condition
Developmental disorder variants found in non-coding genome
This week, we explore new findings that link variants in the non-coding region of the genome to developmental disorders
NHS to launch Innovative Medicines Fund
We look at an initiative that could change the lives of people with rare diseases by giving them access to cutting-edge treatments
DTC testing: time to step in?
As DTC testing becomes more accessible and popular than ever, we ask whether more regulatory work could – and should – be done